Therefore, we evaluated cell death following Mcl-1 mRNA silencing in both LNCaP and PC3 prostate cancer cells, using specific siRNA pools at a concentration between 10 nM and 100 nM (Figure 4A). This evidence concerns the gene MCL1 and prostate cancer.